Clasp founder and CEO Tess Michaels joins Wealth! to discuss her mission of connecting students with employers who will invest in their education and careers. "I actually founded Clasp from a ...
CAMBRIDGE, Mass. & ROCKVILLE, Md.--(BUSINESS WIRE)--Clasp Therapeutics, a biotechnology company bringing unparalleled precision to immuno-oncology using next-generation T cell engagers (TCEs), ...
CAMBRIDGE, MA. & ROCKVILLE, MD.--(BUSINESS WIRE)--Clasp Therapeutics, a biotechnology company bringing unparalleled precision to immuno-oncology using next-generation T cell engagers (TCEs), today ...
Cancer immunotherapy comes in several forms, and one area of growing research interest is a type of drug called a T cell engager. These drugs bind to a cancer cell and a T cell simultaneously, ...
- Clasp's pHLAre™ platform is optimized for tumor-specific antigens, with the potential to yield safer and more effective precision immunotherapies - Preclinical data presented at the 2025 American ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. CLASP inventor and founder/president of Endless Analog, Chris Estes. "We've gone from my ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results